20% of cancer expenditure is thought to inefficient​

SUMMARY: The prevalence, complexity, and costs of cancer are rising – yet, across healthcare, up to 20% of expenditure is thought to be spent on interventions that are deemed inefficient.9 There is thus an urgent need to ensure that cancer care is delivered
as efficiently as possible for the sustainability of our healthcare systems.

Continue reading